The University of Texas MD Anderson Cancer Center today named Rosanna Morris, RN, MBA, as chief operating officer (COO). With more than 20 years of leadership experience in clinical and hospital operations, planning and patient care, Morris will begin her new duties overseeing inpatient and outpatient operations on April 22.
Morris currently is president of Beaumont Hospital, Royal Oak, a 1,100-bed academic medical center affiliated...
The University of Texas MD Anderson Cancer Center and Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly...
By analyzing variations in the level of human papillomavirus (HPV) in head and neck cancers, researchers at The University of Texas MD Anderson...
The University of Texas MD Anderson Cancer Center and Nanobiotix today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers, with the first trials to be launched in 2019.
The collaboration will expand clinical development of NBTXR3, a first-in-class agent designed...
The University of Texas MD Anderson Cancer Center and 4D pharma today announced a strategic collaboration to evaluate 4D’s live biotherapeutic...
Waun Ki Hong, M.D., a trail-blazing physician-scientist and mentor whose clinical research innovations led to successful organ-sparing cancer...